Cannabis and Neuropsychological Functioning: An Update on Adverse Effects in Adolescence and Beyond
The International Neuropsychological Society is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Neuropsychological Society maintains responsibility for this program and its content.
- Discuss the magnitude of neuropsychological deficits associated with cannabis use
- Describe neuropsychological domains most affected by cannabis use
- List factors that may moderate adverse effects of cannabis
- Describe future research design considerations to further knowledge in this area
|Availability:||Date Available: 2020-12-03|
|You may obtain CE for this webinar at any time.|
|Offered for CE||Yes|
|Refund Policy||This webinar is not eligible for refunds|
Public sentiment and laws around the use of cannabis continue to become more permissive in the United States alongside a growing perception of effective medicinal applications. Yet, there is a robust literature documenting cannabis-associated worsening of neuropsychological functioning. What does the current scientific research suggest about the type and magnitude of neuropsychological side-effects from recreational and medical use of cannabis? How have results from meta-analyses and large longitudinal studies contributed to our current understanding? Are findings similar in adolescent and adult samples? What factors contribute to poorer or better neuropsychological outcomes? What future research is needed to understand who may be more vulnerable or resilient to adverse effects of cannabis on neuropsychological functioning. This seminar will provide an update of the scientific literature addressing the aforementioned questions.